Literature DB >> 15627760

Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.

Marianne J Engelhart1, Annemieke Ruitenberg, John Meijer, Amanda Kiliaan, John C van Swieten, Albert Hofman, Jacqueline C M Witteman, Monique M B Breteler.   

Abstract

Antioxidants prevent oxidative stress that possibly causes neuronal loss in Alzheimer's disease (AD). We examined whether high plasma levels of the antioxidant vitamins A and E were associated with lower prevalence of AD or cognitive decline (CD). We performed a cross-sectional study within the Rotterdam Study. In an univariate model, higher levels of vitamins A and E were significantly associated with lower prevalence of AD. However, when additional adjustments were made for important confounders, such as age, gender and total cholesterol, the relation substantially weakened -- odds ratios per standard deviation increase were 0.87 (95% CI 0.64-1.19) for vitamin A and 0.94 (95% CI 0.60-1.48) for vitamin E. Antioxidants were not related to CD in non-demented subjects. Our findings suggest no association between plasma levels of vitamin A and E and AD or CD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627760     DOI: 10.1159/000082884

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  11 in total

Review 1.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

Review 2.  Antioxidant nutrients and age-related cognitive decline: a systematic review of population-based cohort studies.

Authors:  Snorri Bjorn Rafnsson; Vardis Dilis; Antonia Trichopoulou
Journal:  Eur J Nutr       Date:  2013-06-07       Impact factor: 5.614

3.  Analysis of postmortem ventricular cerebrospinal fluid from patients with and without dementia indicates association of vitamin E with neuritic plaques and specific measures of cognitive performance.

Authors:  Kenneth Hensley; Lisa L Barnes; Alexandar Christov; Christy Tangney; William G Honer; Julie A Schneider; David A Bennett; Martha Clare Morris
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Vitamin E use is associated with improved survival in an Alzheimer's disease cohort.

Authors:  Valory N Pavlik; Rachelle S Doody; Susan D Rountree; Eveleen J Darby
Journal:  Dement Geriatr Cogn Disord       Date:  2009-12-10       Impact factor: 2.959

5.  Lower fluid and fruits/vegetable intake in questionable dementia among older Hong Kong Chinese.

Authors:  J Lee; L Lam; J Woo; T Kwok
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

6.  Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.

Authors:  Russell H Swerdlow
Journal:  Pharmaceuticals (Basel)       Date:  2009-12-03

7.  Neuronal and vascular oxidative stress in Alzheimer's disease.

Authors:  Cynthia A Massaad
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

8.  Diminished circulating retinol and elevated α-TOH/retinol ratio predict an increased risk of cognitive decline in aging Chinese adults, especially in subjects with ApoE2 or ApoE4 genotype.

Authors:  Xiaochen Huang; Huiqiang Zhang; Jie Zhen; Shengqi Dong; Yujie Guo; Nicholas Van Halm-Lutterodt; Linhong Yuan
Journal:  Aging (Albany NY)       Date:  2018-12-20       Impact factor: 5.682

9.  Peripheral reductive capacity is associated with cognitive performance and survival in Alzheimer's disease.

Authors:  Luisa Minghetti; Anita Greco; Maria Puopolo; Marc Combrinck; Donald Warden; A David Smith
Journal:  J Neuroinflammation       Date:  2006-03-03       Impact factor: 8.322

Review 10.  Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis.

Authors:  May A Beydoun; Hind A Beydoun; Alyssa A Gamaldo; Alison Teel; Alan B Zonderman; Youfa Wang
Journal:  BMC Public Health       Date:  2014-06-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.